Main Article Content

Abstract

Metaplastic carcinoma is a diverse subgroup of invasive breast cancer (IBC) characterised by differentiation of the neoplastic epithelium into squamous cells and/or mesenchymal-looking components, such as but not limited to spindle, chondroid and osseous cells. [1] The clinical characteristics are comparable to those of ER-negative IBC of no special type (NST), although they are more likely to present at an advanced stage. The aetiology is complicated and doesn't seem to be different from IBC-NST (especially the triple-negative subtype). [2] They account for 0.2-1 % of all IBCs. This variation in prevalence stems from the different definitions of metaplastic carcinoma used by different authors.

Article Details

How to Cite
Kumaran Chinnappa, & Sangeetha N. (2023). Metaplastic Carcinoma Masquerading as Tuberculous Mastitis – An Interesting Case Report. Journal of Evolution of Medical and Dental Sciences, 12(9), 294–296. https://doi.org/10.14260/jemds.v12i9.493

References

  1. Hasdemir O, Tokgöz S, Köybaşioğlu F, et al. Clinicopathological features of metaplastic breast carcinoma. Adv Clin Exp Med 2018;27(4):509-13.
  2. Jagtap SV, Bhosale SJ, Kshirsagar AY, et al. Matrix-producing metaplastic breast carcinoma - a rare malignancy. Am J Case Rep 2013;14:213-5.
  3. Cha N, Wang S, Lv M, et al. breast metaplastic squamous cell carcinoma diagnosed with fine needle and core biopsy: a case study. Am J Case Rep 2018;19:203-6.
  4. WHO classification of tumours editorial board: breast tumours. 5th edn. Lyon, France: International Agency for Research on Cancer 2022.
  5. Toumi Z, Bullen C, Tang ACS, et al. Metaplastic breast carcinoma: a case report and systematic review of the literature. Pathol Int 2011;61(10):582-8.
  6. Bigotti G, Di Filippo S, Di Filippo F, et al. An unusual case of metaplastic breast carcinoma following neoadjuvant chemotherapy. Pathol Int 2012;62(1):72-4.